The largest database of trusted experimental protocols

Fastprep 24 5g homogeniser

Manufactured by MP Biomedicals
Sourced in United States

The FastPrep-24™ 5G homogeniser is a laboratory equipment designed for efficient sample disruption and homogenisation. It utilises advanced high-speed agitation technology to effectively disrupt a wide range of sample types, including tissues, cells, and other biological materials, in preparation for further analysis or processing.

Automatically generated - may contain errors

8 protocols using fastprep 24 5g homogeniser

1

RNA Extraction from Seminal Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seminal vesicle samples were homogenised using the FastPrep-24 5G homogeniser (MP Biomedicals, Irvine, CA) with the Cool Prep Adaptor (2 × 1 min, 4.0 m/s, at 4 °C) in Trizol reagent (ThermoFisher Scientific, Waltham, MA). Total RNA was extracted using the Trizol RNA method and DNase treated using RQ1 RNase free DNase (Promega, Madison, WI), following the manufacturer’s instructions. RNA was quantified using a NanoDrop Lite Spectrophotometer (ThermoFisher Scientific) and RNA integrity was assessed using an Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA). RNA with a RIN > 7 was used in this study. Genomic DNA removal was assessed as described [107 (link)]. RNA was stored at − 80 °C prior to use.
+ Open protocol
+ Expand
2

DNA Extraction from Sponge and Water Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
For next generation sequencing DNA was extracted from homogenised sponge samples and water filters using QIAamp PowerFecal Pro DNA kit (Qiagen) according to the manufacturer’s protocol. An additional incubation step was added prior to homogenisation in order to increase DNA yields: samples were incubated at 65 °C for 10 min (inverted by hand three times after 5 min) and transferred onto ice. The homogenisation protocol was altered to a speed setting of 4 for 30 s using FastPrep-24 5G homogeniser (MP Biomedicals), pause on ice 5 min and homogenisation repeated as before.
+ Open protocol
+ Expand
3

Extracting Bacterial Genomic DNA from Digesta

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial genomic DNA was extracted from 250 mg digesta using a commercial kit, NucleoSpin Tissue Mini Kit for DNA from cells and tissue (NucleoSpin, Macherey & Nagel, Düren, Germany) according to the manufacturer’s instructions with the following exceptions: bead beating of 250 mg digesta in 1 mL of pre-lysis solution was carried out on a FastPrep-24™ 5G homogeniser (MP Biomedicals, LLC, Santa Ana, CA, USA) at a speed of 6 m/s for 10 min (4 times 5 × 30 s and 15 s cooling pause); Proteinase K treatment lasted for 30 min at 56 °C. The following steps were performed as described by the manufacturer, but the volume of the elution buffer was doubled to increase DNA yield. According to the manufacturer’s instructions, DNA concentration was determined using Promega QuantiFluor® dsDNA System (Promega, Corporation, Madison, Wisconsin, USA). DNA extracts were subjected to amplicon sequencing using an Illumina NextSeq500 sequencer (LGC, Berlin, Germany) with 150 bp-paired reads using 16S rDNA primers 341f and 785r. Demultiplexing was achieved with Illumina bcl2fastq (v. 2.17.1.14); paired reads were combined with BBMerge (v. 34.48).
+ Open protocol
+ Expand
4

Fecal DNA Extraction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA from faecal samples (0.2 g) was extracted using the QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany) following the manufacturer’s instructions. The extraction protocol was preceded by repeated bead-beating on a FastPrep-24™ 5G homogeniser (MP Biomedicals, LLC, Santa Ana, CA, USA) to increase DNA extraction performance from spore-forming [17 (link)] and possibly the gram-positive bacteria.
+ Open protocol
+ Expand
5

EBV Detection in PDX Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Snap-frozen PDX tumour fragments were homogenised using the FastPrep24-5G homogeniser (MP Biomedicals, #116005500) in lysing matrix D tubes and DNA was extracted using the Qiagen AllPrep DNA/RNA/Protein Mini Kit following the manufacturer’s instructions (Qiagen, #80004). A common region of EBV nuclear antigen 1 and 2 (EBNA) was detected using the previously published primers EBNA-2F 5′-TGGAAACCCGTCACTCTC-3′ and EBNA-2I 5′-TAATGGCATAGGTGGAATG-3′ (PCR product = 801 bp) [37 (link)]. DNA was amplified using GoTaq G2 Flexi DNA polymerase (Promega, #M7801) according to the manufacturer’s instructions. Cycling conditions: 94 °C for 2 min, 35 cycles of 94 °C for 1 min, 58 °C for 90 s, 72 °C for 4 min, followed by 72 °C for 10 min. Genomic DNA from Raji cells, a human B lymphoblastoid cell line, served as an EBV positive control.
+ Open protocol
+ Expand
6

Fecal DNA Extraction with QIAmp® Kit

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from aliquots of individual fecal samples (n = 220; ~200 mg each; following the removal of ethanol and sample rehydration) using a QIAmp® PowerFecal Pro DNA Kit (Qiagen, Germany) according to the manufacturer's instructions with slight modifications: (i) the cell lysis step was performed using 800 μL of solution CD1 employing a FastPrep-24™ 5 G homogeniser (MP Biomedicals); and (ii) DNA was eluted twice using 50 μL of solution C6, the 2 eluates combined and the samples then stored at −20°C until further processing.
+ Open protocol
+ Expand
7

Protein Extraction and Western Blot for CU-PC01 Tumours

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein was isolated from snap-frozen CU-PC01 tumours using RIPA buffer (Universal Biologicals Ltd., Cambridge, UK #39244.01) supplemented with a protease/phosphatase inhibitor cocktail (Cell Signalling Technology, Leiden, Netherlands, #5872S) and homogenised with 1.4 mm ceramic beads (VWR, Leicestershire, UK, #432-0372P) in a FastPrep24-5G homogeniser (MP Biomedicals, CA, USA, #116005500). Protein concentrations were determined using a Bradford assay (Bio-Rad, Watford, UK, #5000205), before equal amounts of protein were separated using 10% Mini-PROTEAN TGX gels (Bio-Rad, #4561034) and transferred onto mini PVDF membranes (Bio-Rad, #1704156) using the trans-blot turbo transfer system (Bio-Rad, #1704150). Membranes were blocked in 5% BSA (Sigma), incubated with the primary antibody overnight at 4 °C, the secondary antibody for 1 h at room temperature and protein detected using the Clarity ECL substrate (Bio-Rad, #1705061) and the ChemiDoc Imaging System (Bio-Rad). Primary antibodies included Cell Signalling Technology antibodies p-AKT T308 1:1000 (#13038), AKT 1:1000 (#9272) and GAPDH 1:2000 (#5174), and BD Biosciences antibody RB 1:1000 (#554136). Secondary anti-rabbit-HRP (#7074) and anti-mouse-HRP (#7076) antibodies were sourced from Cell Signalling Technology.
+ Open protocol
+ Expand
8

Pig Lung Dissection and Antibiotic Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dissection and infection of pig lungs were performed as described in Harrison et al. [9] .
Briefly, pig bronchioles were dissected, UV sterilised and transferred to 24-well plates with 400 µL of 0.8% agarose/ASM (Artificial Sputum Medium [14] ) as a pad. Bronchiole tissues were infected with the bacterial isolates using a syringe and 500 µL of ASM were added to each well. Uninfected bronchiole tissues were used as negative controls. Plates were then covered with UV sterilised breathable membranes (Sigma Aldrich) and incubated at 37°C for 7 days. Tissues were then washed in 500 µL of PBS, transferred to sterile bead tubes containing 1 gm of metal beads (2.4 mm, Fisher Scientific) and 1 mL of PBS, and homogenised using a FastPrep-24™ 5G homogeniser (MP Biomedicals) for 40 sec at 4.0 m/sec. Biofilm homogenate was transferred to 96-well plates, serially diluted and plated on LB agar plates for calculating the bacterial load.
Replicate infected tissues were treated with antibiotics by transferring the washed infected tissues to 48-well plates containing 300 µL of either MHB or ASM containing ciprofloxacin (Thermo Fisher), meropenem (Sigma), tobramycin (Thermo Fisher) or combination therapy at the specified concentrations and incubated at 37°C for 24 hours. Antibiotic-treated tissues were then washed, homogenised and plated as previously described.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!